Getting really cheap helped.
But while it is clear that for someone with mysterious symptoms or with a family history of disease, genome sequencing offers clear benefits, it’s a bit more complicated for persons who want to be sequenced in order to reveal risks of future health problems.
Genomics is indeed making great progress, and although I applaud Google for dedicating some of its own scientific efforts to genomics, it's not helpful to exaggerate what they've done so far, especially when they take it to this level. Both the Google news release and the Wired article contain the sort of overstatements that make the public distrust science reporting. We don't need to do that to get people excited about science.
There’s no doubt that the emergence of genomics was a huge scientific breakthrough. It supercharged research in any number of disciplines, and essentially created new ones such as microbiomics.
Genomics research holds the key to meeting many of the global healthcare challenges of the years ahead. In the last few years, costs for genetic testing have plummeted, as advances in sequencing technology have made individual genome sequencing economically feasible. Remarkable advances in genomics technologies, including pharmacogenomics, direct-to-consumer genomics, and wearable data-collection devices are leading to large pools of stored data.
Artificial intelligence has become the pet anxiety of luminaries like Elon Musk, Bill Gates, and Stephen Hawking. They have all expressed concerns about our Promethean quest to develop machine intelligence, and those concerns seem to be spreading every day.
But there’s another dimension of technological change that ought to worry us every bit as much as AI, if not more so.
Bioengineering has already allowed human beings to take control of their own evolution. Whether it’s emergent cloning technologies or advanced gene therapy, we’re quickly approaching a world in which humans can — and will — change the way they live and die.
One of the newest genomic technologies that is causing considerable ethical consternation is CRISPR-cas9, which is expected to be the largest and fastest-growing segment of the global genome editing market over the next five years.
Even highly accurate genetic sequences can have hundreds of thousands of errors—and it only takes a few.
But as the personal genomics company grows, convincing more and more people to send their spit off to a lab in exchange for data about their DNA, what is it doing about privacy?
The prospect is spurring both intrigue and concern in the life sciences community because it might be possible, such as through cloning, to use a synthetic genome to create human beings without biological parents.
Genetic testing data can be subpoenaed, stolen, and sold as a commodity. So why is the industry booming?
Personal genetics can empower patients, doctors, and researchers to make more informed decisions around health care. But while this information could help us make better medical choices, it could also be used to fine-tune insurance algorithms, calculating premiums on a sliding scale of genetic risk.
Researchers worry about misinforming people about the risk of disease.
How will law enforcement handle the deluge of new information available from DNA?
Genomics is not a pseudoscience or a hoax. It is an immensely important discipline that has yielded many insights about the human condition and will continue to do so. But putting it to use is far harder than many of its enthusiasts have led the public to believe.
The principal aim of BioNews is to provide accurate, balanced and timely news and comment on genetics, assisted conception, embryo/stem cell research and related areas.
Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication.
The Genome News Network (GNN) produces a lively and trusted online magazine that covers important developments in genomics research around the world. Our news coverage focuses on stories about genomics and human medicine, as well as the ways in which scientists are using genomics to find biological solutions to energy needs and environmental problems.
The objective of this site is to be a one stop location where one can find most of the freely available internet resources related to genomics and bioinformatics.
GeneCards is a searchable, integrated, database of human genes that provides concise genomic related information, on all known and predicted human genes.
The organization works to transform leadership in the genetics community to build capacity in advocacy organizations and to educate policymakers by leveraging the voices of individuals and families.
Genome British Columbia is a research organization that invests in and manages large-scale genomics and proteomics research projects and science and technology platforms focused on areas of strategic importance such as human health, forestry, fisheries, ethics, agriculture, and the environment.
Everyone using GCAT chips is a faculty member working with undergraduates and trying to bring genomics into the curriculum to help students.
The Genome in a Bottle Consortium is a public-private-academic consortium hosted by NIST to develop the technical infrastructure (reference standards, reference methods, and reference data) to enable translation of whole human genome sequencing to clinical practice.
In partnership with Genome Canada Industry Canada and the Province of Alberta, Genome Alberta was established in the fall of 2005 to focus on genomics as one of the central components of the Life Sciences Initiative in Alberta, and to help position the Initiative as a core research effort.
GenomeNet is a Japanese network of database and computational services for genome research and related research areas in biomedical sciences, operated by the Kyoto University Bioinformatics Center.
GenomeWeb’s editorial mission is to serve readers with exclusive, in-depth coverage of the technology, institutions, and scientists that make up the worldwide research enterprise of molecular biology.
Essentials of Medical Genomics fills this need, providing a concise, clearly written guide to the state of the art in genomic research, and explaining in easy-to-follow terms how it is changing the way patients are diagnosed and treated.
The Human Genome Organisation (HUGO) is the international organisation of scientists involved in human genetic and genomic research. Established in 1989 by a collection of the world's leading human geneticists, the primary ethos of the Human Genome Organisation is to promote and sustain international collaboration in the field of human genetics.
A challenge facing researchers today is that of piecing together and analyzing the plethora of data currently being generated through the Human Genome Project and scores of smaller projects. NCBI's Web site serves an an integrated, one-stop, genomic information infrastructure for biomedical researchers from around the world so that they may use these data in their research efforts.
The Society aims to foster discovery and characterization of genomic variations including population distribution and phenotypic associations.
The Human Proteome Organisation (HUPO) is an international scientific organization representing and promoting proteomics through international cooperation and collaborations by fostering the development of new technologies, techniques and training.
An international organisation
dedicated to advanced research and training in molecular biology and biotechnology,
with special regard to the needs of the developing world.
The International Genomics Consortium (IGC) is a non-profit medical research organization established to expand upon the discoveries of the Human Genome Project and other systematic sequencing efforts by combining world-class genomic research, bioinformatics and diagnostic technologies in the fight against cancer and other complex diseases.
A non-profit research institution dedicated to improving human health, nutrition and the environment.
At NHGRI, we are focused on advances in genomics research. Building on our leadership role in the initial sequencing of the human genome, we collaborate with the world's scientific and medical communities to enhance genomic technologies that accelerate breakthroughs and improve lives. By empowering and expanding the field of genomics, we can benefit all of humankind.
Zenome is a decentralized market of genomic data and services.
The American Society of Gene & Cell Therapy is a non-profit medical, scientific, and professional organization devoted to the research and development of therapies that involve the introduction of genetic material and/or cells into the body to treat or prevent disease.
APS aims to promote and facilitate proteomics research in the Australasian region, by organising and managing conferences, instructional courses and workshops.
For more than two decades Dr. J. Craig Venter and his research teams have been pioneers in genomic research.
Patients are at the core of everything we do. Alnylam was founded to help people who lack adequate treatment options live fuller, healthier lives. Their needs drive our discoveries, and their stories further our commitment to delivering innovative therapies.
Avesthagen was founded as a grid of verticals of biodiversity and horizontals of “omics” platforms. It has grown into an internationally recognized pioneer by using systems-biology to facilitate Scientific Discovery & Technology Development, with the aim of delivering innovative products and technologies for Healthcare, Wellness and Agriculture.
is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining.
Cellectis is the worldwide leader in the research, development and commercialization of rational genome engineering technologies. Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination.
Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.
Cancer is detected too late. At Exact Sciences, we’re committed to using our proven expertise and determination to change lives by detecting cancer earlier. We deliver life-changing innovations to give people the confidence to make more effective decisions. That’s our promise.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology.
GenWay Biotech is a leading protein and antibody solutions provider. Our company strives to provide the best value of reagents to the research community. We stand by the data provided in our product datasheets, and we will offer full refunds if products do not meet the established specifications.
IntegraGen is dedicated to gene discovery and the commercialization of molecular diagnostics products and services that provide clinicians with new tools to personalize diagnosis, treatment, and therapy.
Invitae is a leader in advanced medical genetics. Our company was founded with a singular mission: to make genetic information affordable and accessible to everyone who can benefit from it. The Invitae team includes pioneers in genetics, medicine, technology, and genetic counseling, and is trusted by experts to provide the most comprehensive, reliable genetic screening and support available.
A leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics.
Orion Genomics provides genomics research services and clinical laboratory services to leading healthcare and agricultural research organizations.
We develop specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope. We are an Arizona-based, nonprofit medical research institute dedicated to conducting groundbreaking research with life-changing results.
Transnetyx is the trusted automated genotyping resource for thousands of researchers in universities, hospitals, and bioscience companies around the world.
Your source for the
production of high-volume
proteins in the white of
transgenic chicken eggs.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.